|
Press Releases |
|
 |
|
Wednesday, May 28, 2025 |
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully |
The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. more info >> |
|
Tuesday, April 30, 2024 |
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg |
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to overcome the immunosuppressive microenvironment of solid tumors. more info >> |
|
Thursday, October 5, 2023 |
|
Electronics Asia Conference 2023 to Highlight IoT, AI/ML, Automotive, and Wireless Developments Driving Semiconductor Industry Growth in Asia |
Following the huge success of its inaugural edition, the Electronics Asia Conference (EAC), a virtual conference and exhibition organized by AspenCore, the publisher of EE Times Asia, EE Times India, and EDN Asia, is set to take place from October 17 to 19, 2023. more info >> |
|
Tuesday, April 4, 2023 |
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
Monday, September 12, 2022 |
|
Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma |
Eisai and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) today announced the first presentation of results from the final analysis of the Phase 3 LEAP-002 trial investigating LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, plus KEYTRUDA. more info >> |
|
Thursday, August 13, 2020 |
|
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma |
QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable melanoma. more info >> |
|
Tuesday, September 29, 2009 |
|
Next Generation Technologies to Boost Efficiency and Safety for Asia's Chemical Industries; Latest in Process Engineering, Controls, Instrumentation and Scientific Equipment at CIA2009 |
CIA2009, Asia's leading process engineering, controls instrumentation and scientific equipment exhibition gathers the latest technologies and solutions that caters to industry demands to enhance product quality and expand production capacity while improving process safety and plant availability. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Shoucheng Interim Results: Revenue +36%, Asset Finance +69%, Robot Focus
Aug 31, 2025 20:40 HKT/SGT
|
|
|
Hong Kong Watch & Clock Fair, Salon de TIME return in September
Aug 31, 2025 12:30 JST
|
|
|
Genetec reinforces foundation for growth, maintains resilient outlook
Aug 30, 2025 23:59 HKT/SGT
|
|
|
Integrated Development of Four Major Businesses to Drive the Financial 'Five Major Areas', GF Securities Announces its 2025 Interim Results
Aug 30, 2025 16:08 HKT/SGT
|
|
|
Global New Material International Establishes Asia-Pacific Headquarters in Hangzhou, Advancing Global Integration
Aug 30, 2025 10:54 HKT/SGT
|
|
|
Gome Retail's H1 2025 Significant Performance Improvement, Debt Resolution Breakthrough, and Accelerated Strategic Transformation
Aug 29, 2025 22:15 HKT/SGT
|
|
|
CITIC Limited reports solid H1 2025 results with higher dividend
Aug 29, 2025 20:51 HKT/SGT
|
|
|
AI-Powered Foundation, Innovation-Driven Empowerment, Legend Holdings Reports RMB699 Million in Net Profit Attributable to Parent for 2025H1
Aug 29, 2025 19:13 HKT/SGT
|
|
|
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building
Aug 29, 2025 18:54 JST
|
|
|
Analogue 2025 Interim Results Net Profit Reaches HK$80.8 Million
Aug 29, 2025 17:42 HKT/SGT
|
|
|
Black Spade calls for family offices to increase their focus on digital assets and emerging industries
Aug 29, 2025 17:32 HKT/SGT
|
|
|
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma
Aug 29, 2025 18:17 JST
|
|
|
TechInnovation 2025 Returns with 3 Days of Game-Changing Innovation
Aug 29, 2025 16:00 HKT/SGT
|
|
|
Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage
Aug 29, 2025 15:17 JST
|
|
|
JF SmartInvest Holdings Ltd Returns to Profit in 2025 Interim Results
Aug 29, 2025 11:24 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|